These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16219474)

  • 1. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS.
    Veglianese P; Lo Coco D; Bao Cutrona M; Magnoni R; Pennacchini D; Pozzi B; Gowing G; Julien JP; Tortarolo M; Bendotti C
    Mol Cell Neurosci; 2006 Feb; 31(2):218-31. PubMed ID: 16219474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel synthetic analogue of ω-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells.
    Dyari HRE; Rawling T; Chen Y; Sudarmana W; Bourget K; Dwyer JM; Allison SE; Murray M
    FASEB J; 2017 Dec; 31(12):5246-5257. PubMed ID: 28798154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice.
    Bendotti C; Atzori C; Piva R; Tortarolo M; Strong MJ; DeBiasi S; Migheli A
    J Neuropathol Exp Neurol; 2004 Feb; 63(2):113-9. PubMed ID: 14989597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.
    Tortarolo M; Veglianese P; Calvaresi N; Botturi A; Rossi C; Giorgini A; Migheli A; Bendotti C
    Mol Cell Neurosci; 2003 Jun; 23(2):180-92. PubMed ID: 12812752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.
    Raoul C; Estévez AG; Nishimune H; Cleveland DW; deLapeyrière O; Henderson CE; Haase G; Pettmann B
    Neuron; 2002 Sep; 35(6):1067-83. PubMed ID: 12354397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
    Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
    Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis.
    Migheli A; Piva R; Atzori C; Troost D; Schiffer D
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1314-22. PubMed ID: 9413280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
    Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W
    Neurobiol Dis; 2007 May; 26(2):332-41. PubMed ID: 17346981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis.
    Huang G; Lee X; Bian Y; Shao Z; Sheng G; Pepinsky RB; Mi S
    Cell Death Dis; 2013 Oct; 4(10):e841. PubMed ID: 24113175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of ASK-1 and downstream MAP kinases in cytochrome P4502E1 potentiated tumor necrosis factor alpha liver injury.
    Wu D; Cederbaum A
    Free Radic Biol Med; 2010 Aug; 49(3):348-60. PubMed ID: 20438834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
    Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression.
    Tortarolo M; Vallarola A; Lidonnici D; Battaglia E; Gensano F; Spaltro G; Fiordaliso F; Corbelli A; Garetto S; Martini E; Pasetto L; Kallikourdis M; Bonetto V; Bendotti C
    J Neurochem; 2015 Oct; 135(1):109-24. PubMed ID: 25940956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways.
    Han DS; Huang HP; Wang TG; Hung MY; Ke JY; Chang KT; Chang HY; Ho YP; Hsieh WY; Yang WS
    J Cell Biochem; 2010 Oct; 111(3):564-73. PubMed ID: 20568119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.